98%
921
2 minutes
20
A growing body of scientific evidence indicates that exposure to low dose ionizing radiation (< 2 Gy) is associated with a higher risk of developing radio-induced cancer. Additionally, it has been shown to have significant impacts on both innate and adaptive immune responses. As a result, the evaluation of the low doses inevitably delivered outside the treatment fields (out-of-field dose) in photon radiotherapy is a topic that is regaining interest at a pivotal moment in radiotherapy. In this work, we proposed a scoping review in order to identify evidence of strengths and limitations of available analytical models for out-of-field dose calculation in external photon beam radiotherapy for the purpose of implementation in clinical routine. Papers published between 1988 and 2022 proposing a novel analytical model that estimated at least one component of the out-of-field dose for photon external radiotherapy were included. Models focusing on electrons, protons and Monte-Carlo methods were excluded. The methodological quality and potential limitations of each model were analyzed to assess their generalizability. Twenty-one published papers were selected for analysis, of which 14 proposed multi-compartment models, demonstrating that research efforts are directed towards an increasingly detailed description of the underlying physical phenomena. Our synthesis revealed great inhomogeneities in practices, in particular in the acquisition of experimental data and the standardization of measurements, in the choice of metrics used for the evaluation of model performance and even in the definition of regions considered out-of-the-field, which makes quantitative comparisons impossible. We therefore propose to clarify some key concepts. The analytical methods do not seem to be easily suitable for massive use in clinical routine, due to the inevitable cumbersome nature of their implementation. Currently, there is no consensus on a mathematical formalism that comprehensively describes the out-of-field dose in external photon radiotherapy, partly due to the complex interactions between a large number of influencing factors. Out-of-field dose calculation models based on neural networks could be promising tools to overcome these limitations and thus favor a transfer to the clinic, but the lack of sufficiently large and heterogeneous data sets is the main obstacle.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203488 | PMC |
http://dx.doi.org/10.3389/fonc.2023.1197079 | DOI Listing |
Phys Med
August 2025
Princess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand. Electronic address:
Purpose: The aim of this work was to assess secondary cancer risks after rectal cancer intensity modulated radiation therapy (IMRT) and intensity modulated proton therapy (IMPT) using a computational phantom.
Method: A computational male phantom was used to represent Thai rectal cancer patients. Ethos treatment planning system (TPS) was used to calculate the IMRT plan with 12 fields of 6 MV flattening filter free (FFF) photon beams, while matRad was employed to calculate IMPT plans with 2 (lateral and oblique), 3 and 5 fields.
Front Oncol
July 2025
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Introduction: For indolent B-cell non-Hodgkin lymphomas (iNHLs), ultra-low-dose radiation therapy (ULDRT) with 4 Gy has demonstrated durable local control (70%), although distal relapses may occur. Concurrent systemic chemotherapy with radiation therapy (RT) extends progression-free survival (PFS) but is often avoided due to toxicity. We hypothesize that the combination of adaptive ULDRT, with repeat treatment as needed, and single-agent rituximab results in excellent local and systemic control with minimal toxicity.
View Article and Find Full Text PDFClin Transl Radiat Oncol
November 2025
Department of Radiation Oncology, Justus-Liebig-University Giessen, Giessen-Marburg University Hospital, Giessen, Germany.
Introduction: We aimed to evaluate the prevalence and patterns of locoregional recurrence (LRR), outcome and prognostic factors in patients with locally advanced squamous cell carcinoma of the oropharynx, hypopharynx, and larynx treated with intensity-modulated or volume-modulated arc therapy definitive radiotherapy (RT) with or without systemic therapy.
Methods: Of the 213 reviewed patients treated between 2016 and 2023, 177 met the inclusion criteria. LRR was defined as recurrence in the primary tumor region or regional nodes.
Med Oncol
August 2025
Department of Radiation Oncology, The People's Hospital Affiliated to Jiangsu University, 8 Dianli Road, Runzhou District, Zhenjiang City, 212002, Jiangsu Province, China.
This study assessed the efficacy and safety of HyperArc (HA) stereotactic radiotherapy (SRT) in 48 patients with lung cancer brain metastases (LCBM) while identifying prognostic factors and high-risk predictors for symptomatic cerebral radiation necrosis (sCRN). We enrolled 48 patients diagnosed with LCBM at the People's Hospital Affiliated to Jiangsu University between February 2021 and February 2025, assigning 44 to the SRT group and 4 to the WBRT-boost group. Clinical data were collected, and all patients underwent HA stereotactic radiotherapy.
View Article and Find Full Text PDFPhys Med Biol
August 2025
Radiation Protection Dosimetry and Calibration Expert Group, Belgian Nuclear Research Center (SCK CEN), Mol, Belgium.
One major advantage of proton therapy (PT) over conventional photon radiotherapy is reduced dose delivered to normal tissue. However, the complexity of the secondary radiation field composed of a mixture of particles with a wide energy range makes its characterization a challenging task.Measurements with a miniaturized Timepix detector were carried out in three positions out-of-field (7.
View Article and Find Full Text PDF